HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diagnosis of acute respiratory distress syndrome and differentiation from ventilator-associated pneumonia.

Abstract
Acute respiratory distress syndrome (ARDS) remains a significant cause of morbidity and mortality in surgical intensive care unit patients. A relatively predictable sequence of pathophysiologic events occur in the lung, which involve inflammatory mediators and neutrophils. The characteristic radiographic findings of ARDS may mimic ventilator-associated pneumonia (VAP), making the diagnosis of VAP difficult. The standard clinical criteria of fever, leukocytosis, purulent sputum, and infiltrate on chest radiograph are not specific for pneumonia in the surgical patient. The use of bronchoscopy with bronchoalveolar lavage and quantitative cultures can differentiate local and systemic inflammatory response to injury or blood loss from invasive bacterial pneumonia. Basing antibiotic therapy solely on the results of quantitative cultures is safe, because quantitative cultures identify VAP in less than half the patients with clinical evidence of pneumonia. Empiric therapy should be based on the microbiology of the intensive care unit rather than the results of the Gram stain.
AuthorsM A Croce
JournalAmerican journal of surgery (Am J Surg) Vol. 179 Issue 2A Suppl Pg. 26S-29S; discussion 30S (Feb 2000) ISSN: 0002-9610 [Print] United States
PMID10802259 (Publication Type: Journal Article, Review)
Chemical References
  • Anti-Bacterial Agents
Topics
  • Anti-Bacterial Agents (therapeutic use)
  • Diagnosis, Differential
  • Humans
  • Incidence
  • Intensive Care Units
  • Pneumonia, Aspiration (diagnosis, epidemiology, prevention & control)
  • Practice Guidelines as Topic
  • Pseudomonas Infections (drug therapy, pathology)
  • Pseudomonas aeruginosa (pathogenicity)
  • Respiration, Artificial (adverse effects)
  • Respiratory Distress Syndrome (diagnosis, etiology)
  • Risk Factors
  • Staphylococcal Infections (drug therapy, pathology)
  • Staphylococcus aureus (pathogenicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: